Results 181 to 190 of about 272,684 (347)

Mycosis Fungoides in Paediatric Patients: A Real‐Life Retrospective Study

JEADV Clinical Practice, EarlyView.
Our study represents the largest cohort of children with MF worldwide, providing relevant evidence supporting phototherapy as first‐line treatment, with an overall remission rate of 36.36%. Both topical and systemic therapy also showed favourable outcomes.
Mariana de la Vega, María Antonieta Domínguez Gómez, Martha Alejandra Morales‐Sánchez   +2 more
wiley   +1 more source

Representation of Psoriasis on the Web for Patients With Skin of Color. [PDF]

JMIR Dermatol
Nguyen D, Le V, Nguyen D, Han V.
europepmc   +1 more source

An Address ON PSORIASIS AND ITS TREATMENT: Delivered before the Ealing Division of the Metropolitan Counties Branch of the British Medical Association [PDF]

, 1906
Peter Abraham
openalex   +1 more source

Case Report of a Patient With Psoriasis Vulgaris, Psoriatic Arthritis and Alopecia Universalis Successfully Treated With Tofacitinib and Methotrexate

JEADV Clinical Practice, EarlyView.
Capsule Summary We present a case of a 31‐year‐old female with alopecia universalis, psoriasis vulgaris, and psoriatic arthritis, who showed poor response to prior treatments. Following the initiation of a combination therapy with tofacitinib and methotrexate, significant improvements in joint pain and hair regrowth were observed. This case underscores
Jan Nicolai Wagner, Matthias Augustin, Caroline Gewiss, Carolin Grote, Nesrine Ben‐Anaya   +4 more
wiley   +1 more source

Identification of hub genes for psoriasis and thyroid cancer using bioinformatics analysis. [PDF]

Discov Oncol
Shi H, Guo Y, Chen J, Yuan H, Wang L, Zhang Y, Li Y.   +6 more
europepmc   +1 more source

The Relationship of Streptococcus Fecalis to Psoriasis

, 1953
Murry M. Robinson
openalex   +1 more source

Psoriasis Palmaria in Milkers [PDF]

, 1878
George Gaskoin
openalex   +1 more source

Efficacy and Tolerability of Brodalumab in 42 Adult Patients With Moderate to Severe Psoriasis: First French Real‐Life Case Series on Hard‐to‐Treat Areas

JEADV Clinical Practice, EarlyView.
In our real‐life study, brodalumab demonstrates clinical efficacy on psoriasis lesions over a median duration of treatment of 4 months, associated with mean reductions of 94.3% for BSA, 93.1% for PASI and 88.0% for PGA. 23 patients no longer had a single lesion at the follow‐up visit.
Marc Perrussel, Bruno Sassolas
wiley   +1 more source

COVID-19 in patients with psoriasis: A Latin American case series

JAAD International, 2021
Isabela Campo-Slebi, MD, María Fernanda Meza-Corso, MD, Paola Cárdenas, MD, Juan Raúl Castro-Ayarza, MD, Cesar González, MD, Carolina Cortés, MD, Manuel Franco, MD, Fernando Valenzuela, MD   +7 more
doaj  

Successful Treatment with Secukinumab in a Psoriasis Patient on Hemodialysis. [PDF]

Psoriasis (Auckl)
Xiao Y, Sun J.
europepmc   +1 more source